Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...
Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...
DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval, making it the first precision medicine combo for patients with BRCA2-mutated metastatic ...
Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...
Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.
The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the efficacy of the device in eliminating cancer has yet to be established, ...
A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...
University of Westminster provides funding as a member of The Conversation UK. A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results